These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2957133)

  • 1. Preferential activation of helper/inducer T lymphocytes in autoimmune chronic active hepatitis.
    Lobo-Yeo A; Alviggi L; Mieli-Vergani G; Portmann B; Mowat AP; Vergani D
    Clin Exp Immunol; 1987 Jan; 67(1):95-104. PubMed ID: 2957133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T lymphocyte activation is associated with viral replication in chronic hepatitis B virus infection of childhood.
    Vegnente A; Guida S; Lobo-Yeo A; Alviggi L; Daniels H; Toscano P; Nuzzo V; Mieli-Vergani G; Vergani D
    Clin Exp Immunol; 1991 May; 84(2):190-4. PubMed ID: 1827371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro study of expression of interleukin-2 receptors in T-lymphocytes from patients with IgA nephropathy.
    Lai KN; Leung JC; Lai FM
    Clin Nephrol; 1988 Dec; 30(6):330-4. PubMed ID: 2977310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating activated T lymphocytes in autoeczematization.
    Kasteler JS; Petersen MJ; Vance JE; Zone JJ
    Arch Dermatol; 1992 Jun; 128(6):795-8. PubMed ID: 1599265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcoidosis is not associated with a generalized defect in T cell suppressor function.
    Saltini C; Spurzem JR; Kirby MR; Crystal RG
    J Immunol; 1988 Mar; 140(6):1854-60. PubMed ID: 2964485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of interleukin 2 receptor expression associated with decreased antigen-induced lymphocyte proliferation in patients with AIDS and related disorders.
    Prince HE; John JK
    Clin Exp Immunol; 1987 Jan; 67(1):59-65. PubMed ID: 2957130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T lymphocyte subpopulations defined by two sets of monoclonal antibodies in chronic active hepatitis and systemic lupus erythematosus.
    Frazer IH; Mackay IR
    Clin Exp Immunol; 1982 Oct; 50(1):107-14. PubMed ID: 6216997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes.
    Baadsgaard O; Fox DA; Cooper KD
    J Immunol; 1988 Mar; 140(6):1738-44. PubMed ID: 2964481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus.
    Barnaba V; Franco A; Paroli M; Benvenuto R; De Petrillo G; Burgio VL; Santilio I; Balsano C; Bonavita MS; Cappelli G
    J Immunol; 1994 Mar; 152(6):3074-87. PubMed ID: 7511637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis.
    Senaldi G; Portmann B; Mowat AP; Mieli-Vergani G; Vergani D
    Arch Dis Child; 1992 Dec; 67(12):1447-53. PubMed ID: 1489223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T suppressor cell function and number in children with liver disease.
    Nouri-Aria KT; Lobo-Yeo A; Vergani D; Mieli-Vergani G; Eddleston AL; Mowat AP
    Clin Exp Immunol; 1985 Aug; 61(2):283-9. PubMed ID: 2931221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity.
    Salazar-Gonzalez JF; Moody DJ; Giorgi JV; Martinez-Maza O; Mitsuyasu RT; Fahey JL
    J Immunol; 1985 Sep; 135(3):1778-85. PubMed ID: 2991373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Tolerization" of human T-helper cell clones by chronic exposure to alloantigen: culture conditions dictate autocrine proliferative status but not acquisition of cytotoxic potential and suppressor-induction capacity.
    Pawelec G; Brocker T; Busch FW; Bühring HJ; Fernandez N; Schneider EM; Wernet P
    J Mol Cell Immunol; 1988; 4(1):21-34. PubMed ID: 2977949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell subpopulations defined by monoclonal antibodies after HLA-identical sibling marrow transplantation. II. Activated and functional subsets of helper-inducer and cytotoxic-suppressor subpopulations defined by two-colour fluorescence flow cytometry.
    Atkinson K
    Bone Marrow Transplant; 1986 Dec; 1(2):121-32. PubMed ID: 2971408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulatory T subsets in chronic active viral hepatitis: characterization by monoclonal antibodies.
    Pignata C; Vajro P; Troncone R; Monaco G; Ciriaco M
    J Pediatr Gastroenterol Nutr; 1983 May; 2(2):229-33. PubMed ID: 6223993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of interleukin-2 on suppressor T lymphocytes in autoimmune thyroid disease.
    Yoshikawa N; Morita T; Arreaza G; Resetkova E; Mukuta T; Volpé R
    Clin Invest Med; 1995 Apr; 18(2):91-8. PubMed ID: 7788961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte subpopulations in Bancroftian filariasis: activated (DR+) CD8+ T cells in patients with chronic lymphatic obstruction.
    Lal RB; Kumaraswami V; Krishnan N; Nutman TB; Ottesen EA
    Clin Exp Immunol; 1989 Jul; 77(1):77-82. PubMed ID: 2527654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of sub-populations of circulating T lymphocytes in alcoholic cirrhosis using monoclonal antibodies OKT3, 4, 5, Leu 2 and Leu 15. Effect of hepatitis B virus infection].
    Vetter D; Eichler F; Doffoël M; Krzisch C; Gut JP; Willemin B; Reville M; North ML; Keiling R; Bockel R
    Gastroenterol Clin Biol; 1987 Nov; 11(11):790-4. PubMed ID: 2962894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM; Birch RE; Polmar SH
    J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
    Karavodin LM; Golub SH
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.